Global Health Press
XLinkedInFacebook

You may also like

GHP NewsLatest Science

Literature update ViVa week 16-2026

1. MF59-aQIV looks economically persuasive in Korea and Taiwan — but the price assumptions do a lot of the work This modelling study assessed the cost-effectiveness of MF59-adjuvanted quadrivalent influenza vaccine...

22 April, 2026
23 min read
GHP NewsLatest Science

ViVa 16 – NEWS around the globe

Global vaccination policy this week feels less like harmonized orchestration and more like controlled fragmentation—with a purpose. European and Western Pacific advisory groups are quietly locking in 2026–2027...

22 April, 2026
5 min read

List of Abbreviation

Latest Viva Newsletter

GHP ViVa Archives